Atlantic International EBITDA TCAC 5A

Que fait Atlantic International ? SeqLL Inc. develops and sells genetic analysis technologies, focusing on its True Single Molecule Sequencing (tSMS) platform. The company's products enable researchers and clinicians to perform DNA and RNA sequencing without complex sample manipulation, analyzing billions of single molecules per experiment. Its tSMS platform integrates fluorescence-based optical detection with microfluidics and thermal control systems. The primary buyers are research institutions and life sciences companies seeking advanced sequencing solutions for scientific research and development. SeqLL Inc. generates revenue through the sale of its sequencing technologies and related research services. The company's intellectual property and scientific assets across multiple omics fields support its product offerings. The target market includes academic researchers, biotechnology firms, and clinical laboratories requiring high-precision genomic analysis tools. The firm's technology allows for reproducible data generation, appealing to customers focused on accuracy in genetic research. The company's business model centers on developing and commercializing proprietary sequencing technology. Its tSMS platform differentiates itself by eliminating the need for complex sample preparation, offering a streamlined approach to nucleic acid detection. SeqLL Inc. serves the life sciences industry by providing tools that accelerate research in genomics and molecular biology. The firm's products are designed to support both basic research and applied clinical applications in genetic analysis. Atlantic International est l'une des entreprises les plus populaires sur Eulerpool.